Trials / Completed
CompletedNCT01436734
Role of Aprotinin in Glucagon Degradation, Measurement by Radioimmunoactive Method (RIA) I125
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- University Hospital, Gentofte, Copenhagen · Academic / Other
- Sex
- Male
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study was to investigate the role of the Trasylol in glucagon prevention in degradation using radioimmunoactive method with I125. Additionally different incubation time was introduced in human plasma samples after oral glucose stimulation, also in fasted and hypoglycemia blood samples from patients' type 2 diabetes. Since, the structure and the techniques for the glucagon measurement are well described nowadays.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Fasting glycemia | no intervention |
| OTHER | Hypoglycemia | Insulin induced hypoglycemia |
Timeline
- Start date
- 2011-07-01
- Primary completion
- 2012-12-01
- Completion
- 2013-05-01
- First posted
- 2011-09-20
- Last updated
- 2015-07-14
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01436734. Inclusion in this directory is not an endorsement.